Amneal Pharmaceuticals, Inc. (AMRX) Profit Margins
Over the twelve months to 2026-06-30, Amneal Pharmaceuticals, Inc. (AMRX) had gross margin 39.3%, operating margin 14.6%, net margin 5.0%, free cash flow margin 2.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMRXAmneal Pharmaceuticals, Inc.Follow AMRX — free
—
Price chart with a free account
- Market cap
- 6.5B
- P/E TTM
- 41.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 43.1% | 21.7% | 31.5% | 36.7% | 35.5% | 34.3% | 36.5% | 36.9% | 39.3% | |
| Operating margin | -1.2% | -15.3% | 4.6% | 7.3% | -4.3% | 8.5% | 8.9% | 13.1% | 14.6% | |
| Net margin | -1.2% | -37.1% | 3.4% | 0.6% | -12.2% | -3.5% | -4.2% | 2.4% | 5.0% | |
| FCF margin | 10.1% | -2.8% | 16.2% | 9.1% | 0.7% | 12.5% | 8.4% | 8.0% | 2.7% |
USD billions · SEC XBRL
Amneal Pharmaceuticals, Inc. — questions
- What is Amneal Pharmaceuticals, Inc.'s gross margin?
- 39.3% over the twelve months to 2026-06-30.
- What is Amneal Pharmaceuticals, Inc.'s operating margin?
- 14.6% over the twelve months to 2026-06-30.
- What is Amneal Pharmaceuticals, Inc.'s net profit margin?
- 5.0% over the twelve months to 2026-06-30.
Every figure on this page comes from Amneal Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.